REQUEST A DEMO
Total
USD $0.00
Search more companies

Neoregen Sp. z o.o. (Poland)

Main Activities: Pharmacies and Drug Stores
Full name: Neoregen Sp. z o.o. Profile Updated: September 20, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Neoregen Sp. z o.o is a Polish company specializing in the distribution and sale of specialized medical equipment, including blood vessel scanners and medical wires. They also offer a new STET Clean stethoscope disinfection system. Neoregen provides product support, training, and advice for the optimal use of their medical equipment. The company has a current cooperation with specialists from medical facilities and clinics, offering authorized service and technical reviews of medical equipment. Neoregen donated a scanner to the Karol Jonscher Hospital in Lod, and they are dedicated to providing valuable support and useful tools for medical staff.

Headquarters
Ul. Wolnosci 150/43
Jelenia Gora; Dolnoslaskie; Postal Code: 58-500

Contact Details: Purchase the Neoregen Sp. z o.o. report to view the information.

Website: http://www.neoregen.pl

Basic Information
Outstanding Shares:
Purchase the Neoregen Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Neoregen Sp. z o.o. report to view the information.
Incorporation Date:
August 24, 2015
Key Executives
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Neoregen Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-4.24%
Total operating revenue
-1.87%
Operating profit (EBIT)
49.42%
Net Profit (Loss) for the Period
49.42%
Total assets
-22.64%
Total equity
-10.71%
Operating Profit Margin (ROS)
5.4%
Net Profit Margin
5.4%
Return on Equity (ROE)
6.87%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?